Safety
Generate post-market evidence twice as fast at half the cost
How can we help?
Accelerate regulatory safety studies with complete, clinically nuanced data
Define and monitor clinically specific endpoints as care occurs, rapidly assess emerging risks, and generate rigorous real-world evidence for post-market studies and regulatory filings with daily refreshed Truveta Data.
2X faster
Studies
50% of the cost
at
Research-ready data for pregnancy studies and rare populations
Demonstrate safety and replace costly new registries with precise, research-ready cohorts across hard-to-study populations
Quality that starts at the source
Built through direct partnerships with US health systems, Truveta Data is continuously monitored and improved from ingestion onward, creating evidence that is transparent, traceable, and ready for scrutiny.
Example of quality improvement showing increased vital sign completeness after working directly with health system to identify an EHR clinical repository that was not included in the original data feed to Truveta.
De-risk device safety decisions
Quickly understand which devices perform best and where risks concentrate by moving past procedure codes to device-level detail, supporting earlier intervention and better outcomes.
Rapidly adjudicate adverse events
Accelerate adverse event adjudication with imaging linked to raw de-identified clinical notes and complete longitudinal patient records.
Partner with regulatory experts to move science forward
Truveta Evidence Services brings biostatisticians, epidemiologists, and data scientists together to design studies, execute analyses, and deliver auditable evidence across the product lifecycle.
350+
Publications
150K+
Citations
250+
Conference presentations
100+
Regulatory projects across US and global agencies
FDA, EMA, MHRA, CDC, WHO, NIH, state agencies
and more
Additional resources
Case study
Safety evidence trusted by the CDC
Research
Clarifying treatment risk in Alzheimer's disease
Research
Validating survival in device-based therapy
